Payment overview · 2025
General Payments
3 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|General Practice · CAGUAS, PR · NPI 1275592388
Verified facts
CMS Open Payments records show Orlando E Rivera Usera, MD received $104.14 in general payments during 2025 across 3 reported records.
Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 62 claims for Jardiance by this doctor in 2024.
Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNJARDY as an associated drug or biological on 33 records involving 33 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Synjardy by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
3 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $104.14 | 100.0% | 3 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $104.14 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| JARDIANCE Normalized: jardiance |
Drug | Boehringer Ingelheim Pharmaceuticals, Inc. | $104.14 | 3 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 62 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
62 | 11 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference |
2025 | SYNJARDY open payments reported associated product |
CMS Open Payments — General Payments 33 supporting records · 33 recipient NPIs · example record 1222725005 |
Synjardy · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 711 | 157 |
| Atorvastatin Calcium | Atorvastatin Calcium | 650 | 181 |
| Synthroid | Levothyroxine Sodium | 610 | 123 |
| Famotidine | Famotidine | 491 | 117 |
| Clonazepam | Clonazepam | 476 | 86 |
| Losartan Potassium | Losartan Potassium | 460 | 126 |
| Temazepam | Temazepam | 425 | 64 |
| Pantoprazole Sodium | Pantoprazole Sodium | 403 | 101 |
| Metformin Hcl | Metformin Hcl | 364 | 88 |
| Levothyroxine Sodium | Levothyroxine Sodium | 335 | 81 |
| Diclofenac Potassium | Diclofenac Potassium | 327 | 116 |
| Omeprazole | Omeprazole | 312 | 63 |
| Amlodipine Besylate | Amlodipine Besylate | 309 | 80 |
| Azithromycin | Azithromycin | 301 | 213 |
| Simvastatin | Simvastatin | 301 | 81 |
| Metoprolol Succinate | Metoprolol Succinate | 287 | 68 |
| Tamsulosin Hcl | Tamsulosin Hcl | 239 | 52 |
| Lisinopril | Lisinopril | 223 | 59 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 221 | 54 |
| Tizanidine Hcl | Tizanidine Hcl | 221 | 83 |
| Fluticasone Propionate | Fluticasone Propionate | 202 | 81 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 200 | 82 |
| Montelukast Sodium | Montelukast Sodium | 190 | 47 |
| Glimepiride | Glimepiride | 177 | 29 |
| Sertraline Hcl | Sertraline Hcl | 166 | 33 |
| Alprazolam | Alprazolam | 162 | 23 |
| Enalapril Maleate | Enalapril Maleate | 150 | 30 |
| Furosemide | Furosemide | 147 | 39 |
| Glipizide | Glipizide | 138 | 25 |
| Lorazepam | Lorazepam | 126 | 18 |
| Memantine Hcl | Memantine Hcl | 125 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 124 | 30 |
| Sucralfate | Sucralfate | 124 | 41 |
| Hydrochlorothiazide | Hydrochlorothiazide | 116 | 34 |
| Dicyclomine Hcl | Dicyclomine Hcl | 109 | 45 |
| Eliquis | Apixaban | 108 | 19 |
| Finasteride | Finasteride | 108 | 27 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 107 | 29 |
| Donepezil Hcl | Donepezil Hcl | 106 | 27 |
| Lansoprazole | Lansoprazole | 104 | 23 |
| Meclizine Hcl | Meclizine Hcl | 95 | 39 |
| Irbesartan | Irbesartan | 94 | 19 |
| Methylprednisolone | Methylprednisolone | 94 | 83 |
| Atenolol | Atenolol | 92 | 21 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 91 | 25 |
| Nabumetone | Nabumetone | 88 | 24 |
| Xarelto | Rivaroxaban | 88 | 13 |
| Cilostazol | Cilostazol | 87 | 29 |
| Baclofen | Baclofen | 85 | 17 |
| Carvedilol | Carvedilol | 82 | 13 |
| Trazodone Hcl | Trazodone Hcl | 79 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 76 | 37 |
| Tramadol Hcl | Tramadol Hcl | 76 | 20 |
| Alendronate Sodium | Alendronate Sodium | 75 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 74 | 17 |
| Meloxicam | Meloxicam | 73 | 18 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 72 | 19 |
| Diclofenac Sodium | Diclofenac Sodium | 70 | 33 |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 68 | 58 |
| Jardiance | Empagliflozin | 62 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 62 | 17 |
| Escitalopram Oxalate | Escitalopram Oxalate | 60 | 11 |
| Fenofibrate | Fenofibrate | 59 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 58 | 51 |
| Latanoprost | Latanoprost | 58 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 58 | 16 |
| Nifedipine Er | Nifedipine | 55 | 13 |
| Ezetimibe | Ezetimibe | 54 | 17 |
| Candesartan Cilexetil | Candesartan Cilexetil | 51 | 12 |
| Mupirocin | Mupirocin | 51 | 30 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 51 | 11 |
| Diazepam | Diazepam | 50 | 20 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 47 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 45 | 37 |
| Ramipril | Ramipril | 45 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 44 | 12 |
| Levetiracetam | Levetiracetam | 44 | suppressed |
| Prednisone | Prednisone | 44 | 34 |
| Quetiapine Fumarate | Quetiapine Fumarate | 44 | suppressed |
| Bupropion Xl | Bupropion Hcl | 43 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 43 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 42 | 12 |
| Trulicity | Dulaglutide | 42 | suppressed |
| Naproxen | Naproxen | 40 | 14 |
| Terazosin Hcl | Terazosin Hcl | 40 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 39 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 37 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 37 | 14 |
| Mirtazapine | Mirtazapine | 36 | suppressed |
| Spironolactone | Spironolactone | 36 | 12 |
| Estazolam | Estazolam | 35 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 35 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 35 | 28 |
| Allopurinol | Allopurinol | 34 | suppressed |
| Gemfibrozil | Gemfibrozil | 34 | suppressed |
| Naproxen Sodium | Naproxen Sodium | 34 | 12 |
| Pregabalin | Pregabalin | 34 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 33 | suppressed |
| Betamethasone Valerate | Betamethasone Valerate | 32 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 32 | 26 |
| Doxazosin Mesylate | Doxazosin Mesylate | 32 | suppressed |
| Risperidone | Risperidone | 31 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 30 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 30 | suppressed |
| Pentoxifylline | Pentoxifylline | 30 | suppressed |
| Verapamil Er | Verapamil Hcl | 30 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 29 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 29 | suppressed |
| Metronidazole | Metronidazole | 29 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 29 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 28 | suppressed |
| Desonide | Desonide | 27 | 12 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 27 | suppressed |
| Jentadueto Xr | Linagliptin/Metformin Hcl | 27 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 26 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 26 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 26 | suppressed |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 26 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 25 | suppressed |
| Ciclopirox | Ciclopirox | 25 | 21 |
| Fluconazole | Fluconazole | 25 | 19 |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 24 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 24 | suppressed |
| Ketoconazole | Ketoconazole | 24 | 12 |
| Terbinafine Hcl | Terbinafine Hcl | 24 | 16 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 23 | suppressed |
| Anastrozole | Anastrozole | 22 | suppressed |
| Lactulose | Lactulose | 22 | 13 |
| Premarin | Estrogens, Conjugated | 22 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 22 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 22 | suppressed |
| Januvia | Sitagliptin Phosphate | 21 | suppressed |
| Valsartan | Valsartan | 21 | suppressed |
| Acyclovir | Acyclovir | 19 | 11 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Sure Comfort | Syringe-Needle,insulin,0.5 Ml | 19 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 19 | 12 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 18 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | suppressed |
| Humalog | Insulin Lispro | 17 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | 16 |
| Dexlansoprazole Dr | Dexlansoprazole | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 16 | suppressed |
| Glyburide-Metformin Hcl | Glyburide/Metformin Hcl | 16 | suppressed |
| Celecoxib | Celecoxib | 15 | suppressed |
| Cephalexin | Cephalexin | 15 | 14 |
| Clobetasol Propionate | Clobetasol Propionate | 15 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Lidocaine | Lidocaine | 15 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 15 | suppressed |
| Primidone | Primidone | 15 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 15 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Carbamazepine Er | Carbamazepine | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Humulin 70/30 Kwikpen | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 14 | suppressed |
| Levofloxacin | Levofloxacin | 14 | 13 |
| Telmisartan | Telmisartan | 14 | suppressed |
| Timolol Maleate | Timolol Maleate | 14 | suppressed |
| Tobramycin | Tobramycin | 14 | 12 |
| Divalproex Sodium | Divalproex Sodium | 13 | suppressed |
| Etodolac | Etodolac | 13 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 13 | suppressed |
| Ibuprofen | Ibuprofen | 13 | suppressed |
| Leflunomide | Leflunomide | 13 | suppressed |
| Tradjenta | Linagliptin | 13 | suppressed |
| Chlorthalidone | Chlorthalidone | 12 | suppressed |
| Desloratadine | Desloratadine | 12 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 12 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Glyburide | Glyburide | 12 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 12 | suppressed |
| Methotrexate | Methotrexate Sodium | 12 | suppressed |
| Ozempic | Semaglutide | 12 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 11 | suppressed |
| Levoxyl | Levothyroxine Sodium | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Mesalamine | Mesalamine | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Pen Needles | Pen Needle, Diabetic | 11 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 11 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $104.14 · 3 records | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error